Yang Wu, PhD

Crinetics Pharmaceuticals
San Diego, United States

Disclosure information not submitted.

Presentation(s):

• ORF32-04 - Once Daily Atumelnant (CRN04894) Enables Lowering of Glucocorticoid Doses with Sustained Androgen Reduction in Adults with Congenital Adrenal Hyperplasia

  Sunday, June 14, 2026
  2:10 PM - 2:25 PM CT